Market Cap for AstraZeneca (AZN)
According to AstraZeneca's latest reported financial statements, the company's latest reported market cap is $137.07B USD. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
AZN
Currently viewingMarket CapSwitch metric
Latest period
$137.07B
YoY change
+5.5%
5Y CAGR
+11.8%
Peak year (2026)
$144.64B
Latest annual
$144.64B
Market Cap history chart for AstraZeneca (AZN) from 1993 to 2026
Market Cap history table for AstraZeneca (AZN) from 1993 to 2026
| Fiscal year | Period ended | Reported | Market Cap | YoY |
|---|---|---|---|---|
| 2026 | $144.64B | +5.5% | ||
| 2025 | $137.07B | +34.9% | ||
| 2024 | $101.59B | -3.2% | ||
| 2023 | $105.01B | -1.2% | ||
| 2022 | $106.25B | +28.5% | ||
| 2021 | $82.66B | +24.7% | ||
| 2020 | $66.31B | +0.9% | ||
| 2019 | $65.70B | +36.5% | ||
| 2018 | $48.12B | +9.5% | ||
| 2017 | $43.96B | +28.9% | ||
| 2016 | $34.10B | -20.3% | ||
| 2015 | $42.79B | -3.8% | ||
| 2014 | $44.48B | +20.5% | ||
| 2013 | $36.90B | +23.5% | ||
| 2012 | $29.87B | -5.6% | ||
| 2011 | $31.64B | -5.3% | ||
| 2010 | $33.40B | -1.9% | ||
| 2009 | $34.03B | +14.2% | ||
| 2008 | $29.81B | -7.1% | ||
| 2007 | $32.07B | -23.3% | ||
| 2006 | $41.80B | +6.3% | ||
| 2005 | $39.32B | +29.2% | ||
| 2004 | $30.44B | -25.0% | ||
| 2003 | $40.59B | +33.3% | ||
| 2002 | $30.44B | -25.7% | ||
| 2001 | $40.96B | -10.0% | ||
| 2000 | $45.53B | +22.8% | ||
| 1999 | $37.07B | +77.0% | ||
| 1998 | $20.95B | +22.4% | ||
| 1997 | $17.12B | +29.1% | ||
| 1996 | $13.26B | +44.0% | ||
| 1995 | $9.20B | +41.9% | ||
| 1994 | $6.48B | +22.9% | ||
| 1993 | $5.28B | — |
Market Cap values are taken from AstraZeneca's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2026's annual market cap for AstraZeneca (AZN) came in at $144.64B – grew 5.5% year-over-year.
Over 2021–2026 (5 years), AstraZeneca market cap expanded at a +11.8% compound annual rate, sustaining 2 straight years of year-over-year growth.
2026 marks the peak market cap at $144.64B, with the historical low of $5.28B recorded in 1993.
Within Healthcare, AstraZeneca (AZN) ranks 9th among 8 peers we track. The peer median for market cap is $302.51B.
AstraZeneca Market Cap by Year
AstraZeneca Market Cap 2026: $144.64B
AstraZeneca market cap in 2026 was $144.64B, grew 5.5% from 2025. This figure represents the highest annual value in the available history.
AstraZeneca Market Cap 2025: $137.07B
AstraZeneca market cap in 2025 was $137.07B, surged 34.9% from 2024.
AstraZeneca Market Cap 2024: $101.59B
AstraZeneca market cap in 2024 was $101.59B, edged down 3.2% below 2023.
AstraZeneca Market Cap 2023: $105.01B
AstraZeneca market cap in 2023 was $105.01B, edged down 1.2% below 2022.
AstraZeneca Market Cap 2022: $106.25B
AstraZeneca market cap in 2022 was $106.25B.
See more financial history for AstraZeneca (AZN).
Sector peers — Market Cap
Companies in the same sector as AstraZeneca, ranked by their latest market cap.
| Company | Market Cap | Sector |
|---|---|---|
| Eli Lilly and Company (LLY) | $825.77B | Healthcare |
| Johnson & Johnson (JNJ) | $548.34B | Healthcare |
| AbbVie Inc. (ABBV) | $349.67B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $332.91B | Healthcare |
| Merck & Co., Inc. (MRK) | $272.11B | Healthcare |
| Amgen Inc. (AMGN) | $183.05B | Healthcare |
| Novo Nordisk A/S (NVO) | $182.96B | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | $174.74B | Healthcare |
Frequently asked questions
What is AstraZeneca's market cap?
- Latest reported market cap for AstraZeneca (AZN) is $137.07B (period ending December 31, 2025).
How has AstraZeneca market cap changed year-over-year?
- AstraZeneca (AZN) market cap changed +5.5% year-over-year on the latest annual filing.
What is the long-term growth rate of AstraZeneca market cap?
- AstraZeneca (AZN) market cap compound annual growth rate is +11.8% over the most recent 5 years available.
When did AstraZeneca market cap hit its highest annual value?
- AstraZeneca market cap reached its highest annual value of $144.64B in 2026.
What was AstraZeneca market cap in 2025?
- AstraZeneca (AZN) market cap in 2025 was $137.07B.
What was AstraZeneca market cap in 2026?
- AstraZeneca (AZN) market cap in 2026 was $144.64B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
AZN Overview
Company profile, financial tools, and key metrics
AZN Revenue Counter
Earns $1,863 every second. See per minute, hour, and day.
AZN Earnings Counter
Earns $324.23 per second net profit. See per minute, hour, and day.
AZN Economic Scale
Exceeds Bolivia's GDP. Compare with world economies.
AZN What If Invested
What if you had invested $1,000? See historical returns from any date.
AZN How It Makes Money
Discover visual breakdown of $58.74B in revenue — where it comes from and where it goes.
AZN Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
AZN Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
AZN Daily Price Character
Steady · 49.4% historical win rate (green days). Streaks & record days.
AZN Buybacks
0.16% TTM buyback yield. Shareholder yield & SBC comparison.
AZN Stock Split History
3 splits on record. Dates, ratios, and cumulative multiple.
AZN Dividend Profile
Yield: 1.73%. Safety: 6/8. See full history.
AZN Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
AZN Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.